Active substance
Ethacrynic acid
- US FDA 17
- Health Canada 2
- US price lines 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| EDECRIN | 25MG | tablet · oral | BAUSCH | Prescription | 10 Jan 1967 |
| EDECRIN | EQ 50MG BASE/VIAL | injectable · injection | BAUSCH | Prescription | 10 Jan 1967 |
| ETHACRYNATE SODIUM | EQ 50MG BASE/VIAL | injectable · injection | PH HEALTH | Prescription | 29 Jul 2015 |
| ETHACRYNIC ACID | 25MG | tablet · oral | ADAPTIS | Prescription | 30 Jun 2016 |
| ETHACRYNATE SODIUM | EQ 50MG BASE/VIAL | injectable · injection | ZYDUS PHARMS | Prescription | 17 Nov 2017 |
| ETHACRYNIC ACID | 25MG | tablet · oral | AMNEAL PHARMS CO | Prescription | 8 May 2018 |
| ETHACRYNIC ACID | 25MG | tablet · oral | AGNITIO | Prescription | 12 Jul 2019 |
| ETHACRYNIC ACID | 25MG | tablet · oral | SCIEGEN PHARMS | Prescription | 27 Aug 2019 |
| ETHACRYNIC ACID | 25MG | tablet · oral | LUPIN | Prescription | 6 Sep 2019 |
| ETHACRYNIC ACID | 25MG | tablet · oral | UPSHER SMITH LABS | Prescription | 19 Feb 2020 |
| ETHACRYNATE SODIUM | EQ 50MG BASE/VIAL | injectable · injection | STERIMAX | Prescription | 9 Jun 2020 |
| ETHACRYNIC ACID | 25MG | tablet · oral | CHARTWELL RX | Prescription | 19 Oct 2020 |
| EDECRIN | 50MG | tablet · oral | BAUSCH | Discontinued | 10 Jan 1967 |
| ETHACRYNATE SODIUM | EQ 50MG BASE/VIAL | injectable · injection | MYLAN INSTITUTIONAL | Discontinued | 23 Aug 2016 |
| ETHACRYNIC ACID | 25MG | tablet · oral | HIKMA PHARMS | Discontinued | 23 Feb 2017 |
| ETHACRYNIC ACID | 25MG | tablet · oral | PH HEALTH | Discontinued | 21 Jul 2017 |
| ETHACRYNIC ACID | 25MG | tablet · oral | ALVOGEN | Discontinued | 24 Jul 2018 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| EDECRIN | 02258528 | 25 MG | TABLET · ORAL | BAUSCH HEALTH, CANADA INC. |
| ETHACRYNATE SODIUM | 02462362 | 50 MG / VIAL | POWDER FOR SOLUTION · INTRAVENOUS | STERIMAX INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | ETHACRYNIC ACID 25 MG TABLET | $0.80656 | per EA | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.